Morse Asset Management, Inc
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1705711
DARIEN, CT
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$208,262
-$484,796 QoQ
Shares Held
334
-62.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,043
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $10,205,191 across 7 Biotechnology names. REGN ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,526 | $5,228,579 | |
| 2 | ASND |
Ascendis Pharma A/S
|
9,589 | $2,557,578 | |
| 3 | ARGX |
Argenx SE
|
1,348 | $1,250,633 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
67,649 | $566,222 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
1,378 | $392,688 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
334 | $208,262 | |
| 7 | MANE |
Veradermics, Inc
|
10 | $1,229 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,262 | 334 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $693,058 | 897 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $612,864 | 794 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $394,713 | 702 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $417,375 | 795 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,612,393 | 4,119 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,321,372 | 1,855 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,053,310 | 4,807 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $5,007,106 | 4,764 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,412,054 | 4,584 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,984,801 | 4,537 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $3,379,896 | 4,107 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,819,550 | 3,924 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,091,944 | 3,763 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,660,855 | 3,688 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,535,041 | 3,680 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,251,023 | 3,808 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,304,087 | 3,299 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,881,298 | 2,979 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,872,426 | 3,094 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $765,199 | 1,370 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $338,768 | 716 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $333,829 | 691 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $439,987 | 786 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $490,188 | 786 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $334,966 | 686 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||